SCHEMBL21976902

SCHEMBL21976902

CCCc1nc([C@H](N)CC)oc1C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.30
PPARA Q07869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466899 0.68 BMP1 (0.42)
SCHEMBL3464044 0.65 C3AR1 (0.36)
SCHEMBL30665042 0.64 PPARG (0.36) PPARGPPARA
SCHEMBL20628462 0.63 ACHE (0.32)
SCHEMBL12262819 0.63 ACHE (0.32)
SCHEMBL5563503 0.62 PPARG (0.37) PPARGPPARA
SCHEMBL18863710 0.62
SCHEMBL28734173 0.62
SCHEMBL8514003 0.61 C3AR1 (0.33)
SCHEMBL20229729 0.60 FBP1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11040960-B2 Inhibitors of CXCR2 CHEMOCENTRYX, INC. (US) 2021-06-22 US disclosed
US-20200140418-A1 INHIBITORS OF CXCR2 CHEMOCENTRYX, INC. 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140418-A1 INHIBITORS OF CXCR2 CXCR2, CXCR3, CXCR1 PPARG 1320/4885PPARA 2902/4885
US-11040960-B2 Inhibitors of CXCR2 CXCR2, CXCR3, CXCR1 PPARG 1320/4885PPARA 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.